SCHEMBL7938993

SCHEMBL7938993

Clc1nc(N2CCOCC2)c2ncnc(N3CCOCC3)c2n1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.49
GAA P10253 1/20 0.49
ADK P55263 1/20 0.48
PTK2 Q05397 1/20 0.45
ADORA2A P29274 1/20 0.45
MAPK1 P28482 3/20 0.45
SMN1; SMN2 Q16637 2/20 0.45
ALDH1A1 P00352 2/20 0.45
HSD17B10 Q99714 1/20 0.45
CHEK1 O14757 1/20 0.44
PDPK1 O15530 1/20 0.44
PAK1 Q13153 1/20 0.44
PIK3CA P42336 3/20 0.44
JAK3 P52333 1/20 0.43
SLC29A1 Q99808 1/20 0.43
NPC1 O15118 1/20 0.43
MAPT P10636 1/20 0.43
HPGD P15428 1/20 0.43
RAB9A P51151 1/20 0.43
AURKA O14965 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8850966 0.91 ADK (0.43) KDM4EGAAADKPTK2ADORA2A
SCHEMBL10662972 0.89 ADK (0.41) KDM4EGAAADKPTK2ADORA2A
SCHEMBL10663828 0.88 ADK (0.41) KDM4EGAAADKPTK2ADORA2A
SCHEMBL10657255 0.88 KDM4E (0.55) KDM4EGAAADKPTK2ADORA2A
SCHEMBL8851858 0.88 PTK2 (0.46) KDM4EGAAADKPTK2ADORA2A
SCHEMBL7930954 0.88 SMN1; SMN2 (0.49) KDM4EGAAADKMAPK1SMN1; SMN2
SCHEMBL8851853 0.87 PTK2 (0.45) KDM4EGAAADKPTK2ADORA2A
SCHEMBL10661136 0.84 SMN1; SMN2 (0.50) KDM4EGAAADKMAPK1SMN1; SMN2
SCHEMBL10660765 0.84 SMN1; SMN2 (0.41) KDM4EGAAADKADORA2AMAPK1
SCHEMBL8851147 0.84 HTT (0.47) KDM4EPTK2MAPK1SMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6232312-B1 ADMINISTERING A COMBINATION OF INDENE AND PYRIMIDO(5,4-D)PYRIMIDINE DERIVATIVES TO TREAT PREPANCREATIC CANCER CELL PATHWAYS, INC. 2001-05-15 US disclosed
EP-0645390-A1 Trisubstituted pyrimido 5,4-d pyrimidines for modulating multidrug resistance, drugs containing these compounds and processes for their preparation Dr. Karl Thomae GmbH (DE) 1995-03-29 EP disclosed